MedTrace Logo

CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions

NCT03214835 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-07-20

No results posted yet for this study

Summary

The study will take place at Rambam medical center, department of Otolaryngology Head and Neck Surgery, for two years. Patients suspected of LPR or laryngeal l tumor and are candidate for laryngeal or hypopharyngeal biopsies will be recruited.

Conditions

  • Laryngeal Disease
  • Laryngeal Tumor
  • Laryngopharyngeal Reflux

Interventions

DEVICE

Endo CDx Brush biopsy

In patients with laryngeal lesion the brush biopsy will be taken with the standard cup biopsy - either in the clinic or in the OR. In LPR patients brush biopsy will be taken in the clinic.

Sponsors & Collaborators

  • Rambam Health Care Campus

    collaborator OTHER

  • CDx Diagnostics

    lead INDUSTRY

Principal Investigators

  • Jacob Cohen, MD · Rambam Health Care Campus

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-08-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03214835 on ClinicalTrials.gov